Biotinylated Human TFPI Protein
Beta LifeScience
SKU/CAT #: BLK-01309P-100UG

Biotinylated Human TFPI on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Human TFPI Protein
Beta LifeScience
SKU/CAT #: BLK-01309P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Human TFPI Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Asp29-Lys282. |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | P10646 |
Target Symbol | TFPI |
Synonyms | LACI; TFPI1; EPI; TFI; convertin; TFPI |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Asp29-Lys282 |
Mol. Weight | The protein has a predicted MW of 32.1 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Oestrogens influence the pathophysiology and development of hormone-sensitive cancers, such as breast cancer. Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation pathway and has recently been associated with breast cancer cell development. |